DUHUNTX
"DUHUNTX" is a word mark owned by Skyhawk Therapeutics, Inc., filed at the USPTO on March 20, 2026. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since September 8, 2026
- Filed
- March 20, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99715547
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns DUHUNTX
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Skyhawk Therapeutics, Inc.
Waltham, United States
Representative
Peter Kunin
Downs Rachlin Martin PLLC
What the mark covers
The products and services DUHUNTX is filed for, grouped by Nice class.
Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Assigned to examiner
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About DUHUNTX
Who owns the trademark "DUHUNTX"?
The USPTO trademark "DUHUNTX" (application 99715547) is owned by Skyhawk Therapeutics, Inc.
What is the status of "DUHUNTX"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull DUHUNTX and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d3f28-0ac9-73dd-b493-3b4abceb7a13
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d3f28-0ac9-73dd-b493-3b4abceb7a13",
"object": "trademark",
"mark_text": "DUHUNTX",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99715547",
"filing_date": "2026-03-20",
"nice_classes": [
5
],
"owners": [
{
"name": "Skyhawk Therapeutics, Inc.",
"entity_id": "ent_01a10cf0-67bd-75cf-9fd3-71754e0fe49f"
}
]
}